HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 161.50
+2.50 (1.57%)
At close: Jun 4, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 20.74 billion as of June 5, 2026.
Market Cap
20.74B
Enterprise Value
19.93B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
161.50
Market Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 20.74B, an increase of 275.65%. That is a compound annual growth rate of 299.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 21.00B | 82.28% |
| Dec 31, 2025 | 11.52B | 108.67% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elixiron Immunotherapeutics (Cayman) Limited | 9.56B |
| Uwell Biopharma | 7.89B |
| Intelligene | 6.44B |
| Obigen Pharma | 3.83B |
| Pet Pharm Biotech | 3.06B |
| BIONET Therapeutics | 2.60B |
| FullHope Biomedical | 1.22B |
| Genomics BioSci & Tech. | 1.20B |